Zusammenfassung
Patienten mit sehr häufigen und schweren Migräneattacken sollten eine Prophylaxe erhalten. Dies dient nicht nur der Reduktion der Schwere und Häufigkeit der Attacken, sondern hilft auch, einen medikamenteninduzierten Dauerkopfschmerz zu vermeiden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Arzneiverordnungsreport (1996). Schwabe/Pfaffrath (Hrsg.), Georg Fischer Verlag
Buring JE, Peto R, Hennekens CH (1990) Low-dose aspirin for migraine prophylaxis. JAMA 264:1711–1713
Diener HC, Brune K, Gerber W-D, Göbel H, Pfaffenrath V (1997) Behandlung der Migräneattacke und Migräneprophylaxe. Dtsch Ärztebl 94:A3092–A3102
Diener HC, Föh M, Iaccarino C, Wessely P, Isler HR, Strenge H, Fischer M, Wedekind W, Taneri Z (1996) Cyclandelate in the prophylaxis of migraine: A randomized, parallel, double-blind study in comparison with placebo and propranolol. Cephalalgia 16:441–447
Diener HC, Limmroth V (1994) The treatment of migraine. Rev Contemp Pharmacother 5:271–284
Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS (1992) Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine. Can J Neurol Sci 19:340–345
Havanka-Kanniainen H, Hokkanen E, Myllylä VV (1988) Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg. Headache 28:607–611
Holroyd KA, Penzien DB, Cordingley GE (1991) Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 31:333–340
Horowski R (1983) Pharmacological effects of lisuride and their potential role in further research. In: Calne DB, Horowski R, McDonald RJWW (Hrsg.) Lisuride and Other Dopamine Agonists. Raven Press, New York, 127–139
Klapper J, on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group (1997) Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 17:103–108
Mastrosimone F, Iaccarino C, de Caterina G (1992) Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine. J Med 23:1–11
Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rapoport AM, Silber CJ, Deaton RL (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281–286
Migraine-Nimodipine European Study Group M (1989) European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura). Headache 29:633–638
Peatfield RC, Fozard JR, Rose CF (1986) Drug treatment of migraine. In: Clifford Rose F (Hrsg.) Handbook of Clinical Neurology, Vol. 4 (48): Headache. Elsevier Science Publishers B.V., Amsterdam, 173–217
Peikert A, Wilimzig C, Köhne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16:257–263
Pfaffenrath V, Scherzer S (1995) Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia S15:14–20
Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Göbel H, Fischer M (1996) Magnesium in the prophylaxis of migraine — a double-blind, placebo-controlled study. Cephalalgia 16:436–440
Sargent J, Solbach P, Damasio H, Baumel B, Corbett J, Eisner L, Jessen B, Kudrow L, Mathew N, Medina J, Saper J, Vijayan N, Watson C, Alger J (1985) A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 25:320–324
Schellenberg R, Bölsche F, Schwarz A, Thorn M, Gerber WD, Niederberger U, Soyka D, Wedekind W (1994) Cyclandelate versus propranolol. Clinical and neurophysiological control of therapeutic efficacy in prophylaxis of migraine. Results of a double blind study. In: Clifford Rose F (Hrsg.) New Advances in Headache Research Vol 4. Smith-Gordon, London, 141–148
Scholz E, Gerber WD, Diener HC, Langohr HD, Reinecke M (1987) Dihydroer-gotamine versus flunarizine versus nifedipine versus metoprolol versus propranolol in migraine prophylaxis. A comparative study based on time series analysis. In: Clifford Rose F (Hrsg.) Advances in Headache Research. John Libey & Co, London, 135–145
Silberstein SD (1996) Divalproex sodium in headache: Literature review and clinical guidelines. Headache 36:547–555
Verspeelt J, De Locht P, Amery WK (1996) Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. Cephalalgia 16: 328–336
Welch KMA (1993) Drug therapy of migraine. New Engl J Med 329:14761482
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Diener, HC. (1999). Prophylaxe. In: Migräne. Optimierte Arzneimitteltherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59858-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-59858-6_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-63950-3
Online ISBN: 978-3-642-59858-6
eBook Packages: Springer Book Archive